Institutional investors purchased a net $2.0 million shares of SCLN during the quarter ended December 2016, and now own 72.31% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STONEPINE CAPITAL MANAGEMENT LLC Bought 1.2 Million shares of SciClone Pharmaceuticals ...
NANTAHALA CAPITAL MANAGEMENT LLC Bought 399.5 Thousand shares of SciClone Pharmaceuticals ...